Nasdaq:US$13.65 (-0.24) | HKEX:HK$21.15 (-0.45) | AIM:£2.30 (+0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases

1 items
a091030